Concepedia

Mary Lee Conder

ML

16

Publications

1.1K

Citations

14

H-Index

1989

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Mary Lee Conder is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1989–2016

16

Publications

16

KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias

Wen-Pin Yang, Paul Lévesque, Wayne A. Little et al. · Proceedings of the National Academy of Sciences · 1997 · 205 citations · Full text

Functional Expression of Two KvLQT1-related Potassium Channels Responsible for an Inherited Idiopathic Epilepsy

Wen-Pin Yang, Paul Lévesque, Wayne A. Little et al. · Journal of Biological Chemistry · 1998 · 198 citations · Full text

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.

G. J. Grover, John R. McCullough, D E Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 177 citations

Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.

John R. McCullough, Diane E. Normandin, Mary Lee Conder et al. · Circulation Research · 1991 · 138 citations

, , +18

Dominant-Negative <i>KvLQT1</i> Mutations Underlie the LQT1 Form of Long QT Syndrome

Fouad Shalaby, Paul Lévesque, Wen-Pin Yang et al. · Circulation · 1997 · 134 citations

Rows per page

1–5 of 16